Takeda Launches ORZEYFUL For Narcolepsy Type 1 In Japan, China; Stock Up

(RTTNews) - Takeda Pharmaceutical Company Ltd. (TAK,4502.T), which explores orexin science, announced on Thursday that O...

By Dhallo News · October 15, 2026 at 9:06 AM IST

(RTTNews) - Takeda Pharmaceutical Company Ltd. (TAK,4502.T), which explores orexin science, announced on Thursday that ORZEYFUL (oveporexton) is now available in Japan and China to treat Narcolepsy Type 1 (NT1), with clinicians gaining first access to prescribe this new class of

SOURCE: Nasdaq

ORIGINAL REPORT: Click here

DHALLO EDITORIAL STATUS: Aggregated & reviewed

Have feedback on this article?Report error or suggestion

Takeda Launches ORZEYFUL For Narcolepsy Type 1 In Japan, China; Stock Up

Read More from Markets

TCS, Infosys, HCLTech, Wipro, TechM: IT stocks gain up to 3.5% today; Nifty IT jumps 9% in 3 days; what's driving rally?

Soybeans Sell the Fact on Chinese Buying

Reliance Jio IPO a win-win for telecom stocks! RIL, Airtel and Vodafone Idea shares rise up to 3.6%- What should you do?

5 minutes. The news that matters.